Core Insights - The Chinese private equity industry is at a pivotal crossroads in 2025, driven by technological advancements and regulatory reforms, particularly in quantitative investment powered by AI [2][4]. - Quantitative private equity has outperformed subjective investment in terms of both the number of funds and performance, marking a significant shift in the industry landscape [2][10]. Group 1: AI and Quantitative Investment - DeepSeek, founded by Liang Wenfeng, launched the AI model DeepSeek-R1, which quickly gained attention for its performance in mathematical and logical reasoning tasks, even surpassing ChatGPT in the U.S. market [4]. - The average return for DeepSeek's affiliated quantitative funds reached ***% from January to November 2025, with a three-year average return of ***% [4]. - Other notable quantitative firms, such as Heiyi Asset and Jinkun Investment, have also integrated AI into their investment strategies, enhancing their performance and operational efficiency [6]. Group 2: Regulatory Changes - In April 2025, new regulations on algorithmic trading were introduced, imposing stricter controls on high-frequency trading and defining abnormal trading behaviors [8]. - These regulations are expected to lead to a shift towards medium and low-frequency strategies, increased focus on machine learning applications, and enhanced risk management practices within the quantitative investment sector [8]. Group 3: Market Dynamics - The number of billion-yuan private equity firms has surpassed 100, with quantitative firms leading this growth, indicating a return to the "double hundred" era in the industry [10]. - By November 2025, the total assets under management for private equity funds reached 22.09 trillion yuan, with private securities investment funds contributing significantly to this growth [15]. Group 4: Performance Metrics - As of November 2025, quantitative long-only products reported an average return of 40.34%, outperforming subjective long-only products, which averaged 34.25% [30]. - Among the billion-yuan private equity firms, those focused on quantitative strategies achieved an average return of 34.40%, significantly higher than the 28.49% average for subjective strategies [30]. Group 5: Talent Movement - The trend of public fund managers transitioning to private equity has intensified, with 304 managers leaving public funds in 2025, many moving to private equity firms [38]. - By December 2025, 859 former public fund managers were working in private equity, with a notable average return of 27.70% for those managing at least three qualifying products [39].

今年年初，Deepseek横空出世，在全球人工智能领域掀起惊涛骇浪，亦为量化投资领域注入了新的活力，叠加年内中小盘风格占优的市场环境下，量化投 资更是火出圈。另外，在刚刚过去的11月，A股市场整体呈现调整态势，交投活跃度降低、投资者风险偏好明显收敛下，以股票策略为主的百亿私募旗下 仍有不少产品逆势创下历史新高，且量化产品占比超过八成！ 为了能更清晰了解量化私募基金的业绩，经笔者统计，在私募排排网上有业绩展示的量化产品共有1833只，今年来收益均值达26.98%，今年来超额（几 何）收益达11.41%；其中量化多头策略产品多达833只，今年来收益和超额（几何）收益分别为40.34%、17.25%，在私募二级策略中居前。 | 排序 | 私募二级策略 | 有业绩展示的量化产品 | 今年来收益均值 | 今年来超额收益均值 | | --- | --- | --- | --- | --- | | 1 | ■化务杀 | 833 | 40.34% | 17.25% | | 2 | 量化CTA | 379 | 16.32% | 13.76% | | 3 | 股票市场中性 | 200 | 9.37% | -4.93% | | 4 ...

本文首发于公众号"私募排排网"。 （点击↑↑ 上图查看详情 ） 私募指数增强策略是以跟踪某一特定指数（如沪深300、中证500、中证1000等）为目标，在严控误差的前提下，通过量化方式调整投资组合， 力求获取超越标的指数一种投资策略。 指数增强 策略的重点也就在于它的 "强"，强过对应指数，也就是跑出正超额收益。 然而在近五年的A股行情中，经历了地缘政治、疫情、关税冲击等一系列不确定性的冲击下，市场跌宕起伏。以沪深300指数为例，2021年-2023 年涨跌幅分别为-5.20%、-21.63%、-11.38%、2024年涨幅为14.68%，今年来延续涨势。 在这种行情下，私募指数增强策略想要跑出自己的 "强"实属不易，而在这近五年行情中，能够连续五年跑出超额收益更是凤毛麟角，为了给予 更有价值的信息，本文按不同指增策略，分别梳理出连续五年跑出正超额收益的产品，供投资者参考。 0 1 沪深300指增：幻方、龙旗、明汯领衔！白鹭资管上榜！ 沪深300指数在2021年-2024年的涨跌幅分别为-5.20%、-21.63%、-11.38%、14.68%，此外，截至11月21日，今年来的涨幅为14.75%；私募排 排网 ...

Core Viewpoint - The article highlights the strong performance of quantitative long products from billion-level private equity firms in the A-share market since August, with average returns significantly increasing for various strategies [1]. Summary by Category Quantitative Stock Selection Products - As of August 22, 2025, there are 234 quantitative long products under billion-level private equity firms, with an average return of ***% this year [1]. - The top-performing products in the quantitative stock selection category have shown an average return close to ***% [1]. Top 10 Products in the "CSI 1000 Index Enhancement" Category - The article lists the top 10 products in the "CSI 1000 Index Enhancement" category, with the leading product being "Mengxi CSI 1000 Quantitative No. 5 A-Class" managed by Li Ji from Mengxi Investment [4]. - Other notable products include "Qianyan Liuhe No. 6 1000 Enhancement B-Class" and "Mingfa Quantitative Small Cap Enhancement No. 1 B-Class" [4]. Top 10 Products in the "CSI 300 Index Enhancement" Category - The leading product in the "CSI 300 Index Enhancement" category is "Jiu Zhang Huan Fang CSI 300 Quantitative Multi-Strategy No. 1," managed by Xu Jin from Ningbo Huan Fang Quantitative [7]. - Other top products include "Mingxuan Stable Growth No. 2" and "Zhengding CSI 300 Index Enhancement No. 1 B-Class" [7]. Top 10 Products in the "CSI 500 Index Enhancement" Category - The article provides a list of the top products in the "CSI 500 Index Enhancement" category, highlighting the competitive performance of various funds [10]. Top 10 Products in the "Other Index Enhancement" Category - The article also details the top products in the "Other Index Enhancement" category, showcasing the diversity of strategies employed by different private equity firms [14]. Notable Firms and Strategies - Mengxi Investment has established a strong reputation with its quantitative strategies, leveraging a team with significant academic backgrounds in quantitative finance [16]. - Ningbo Huan Fang Quantitative has also gained recognition for its high returns, particularly in the CSI 300 Index Enhancement category [19].

Core Viewpoint - The quantitative private equity industry has rapidly developed in recent years, outperforming public quantitative funds in terms of performance, with private equity quantitative index enhancement products showing an average return of 31.11% compared to 22.03% for public funds [2][3]. Summary by Category Performance Comparison - As of August 15, 2025, the average return for 398 private equity index enhancement products is 31.11%, with an excess return of 11.50%. In contrast, 382 public equity index enhancement products have an average return of 22.03% and an excess return of 6.04% [2][3]. - The performance of private equity products across different indices shows significant advantages, particularly in the 中证500 and 中证1000 categories, where private equity products have average returns of 29.40% and 35.25%, respectively [9][12]. Leading Products - In the 沪深300 index enhancement category, the top private equity product is "澎湃权益1号" managed by 刘治平, achieving an excess return of ***% [5][7]. - For the 中证500 index enhancement, "兆信中证500指数增强1号A类份额" managed by 唐越 and 胡晨航 leads with an excess return of ***% [10][11]. - The top product in the 中证1000 index enhancement is "今通量化价值成长六号" managed by 钱伟强, with an excess return of ***% [13][15]. - In the 国证/中证2000 index enhancement, "平方和鼎盛中证2000指数增强21号A期" managed by 吕杰勇 and 方壮 ranks first with an excess return of ***% [17][19]. Market Environment - The strong performance of quantitative strategies is attributed to the structural characteristics of the A-share market in the first half of 2025, where small and mid-cap stocks have continued to outperform, and individual stock volatility has increased, creating an ideal trading environment for quantitative strategies [3].

Core Viewpoint - The quantitative private equity industry has seen significant growth in performance this year, driven by market liquidity recovery and better performance in small-cap sectors, with many mid-sized firms entering the ranks of top private equity firms [3][4]. Group 1: Market Performance and Growth - As of July 31, there are 75 top quantitative private equity firms managing over 5 billion, with 17 firms entering this category in 2023 [3]. - Among the top firms, 44 manage over 10 billion, while 31 are in the 5-10 billion range [4]. - The average returns of at least 50 top firms have been positive this year, with specific firms like Stable Investment and Abama Investment leading in performance [4][5]. Group 2: Key Players and Control - 72 out of 75 top quantitative private equity firms are controlled by individuals, accounting for 96% of the total, with only 3 firms under institutional control [4]. - Notably, Liang Wenfeng is the only individual controlling two top firms, Ningbo Huafang Quantitative and Jiu Zhang Asset [4][5]. - The top quantitative private equity firms are often led by individuals with strong backgrounds in finance and technology, contributing to their success [9][10]. Group 3: Performance Rankings of Key Individuals - The top performers among individual controllers include Xie Xiaoyang from Tianyan Capital and Yin Tao from Stable Investment, with their respective products achieving significant average returns [14][15]. - The average returns for the top 10 individual controllers range from ***% to ***%, showcasing their effectiveness in managing funds [10][11]. - Liang Wenfeng, a prominent figure in the industry, has been recognized for his contributions and leadership in the quantitative investment space [7][8].

Core Viewpoint - The recent implementation of quantitative trading regulations aims to enhance the precision of high-frequency trading supervision and impose strict constraints on abnormal trading, reshaping the market ecology and promoting the standardized development of the quantitative industry [2] Group 1: Quantitative Long Strategy Performance - The article highlights the performance of quantitative long products in the first half of the year, focusing on those with assets under management exceeding 500 million [2] - The top-performing quantitative long products are categorized by strategies such as quantitative stock selection, CSI 500 index enhancement, CSI 1000 index enhancement, and CSI 300 index enhancement [2] Group 2: Quantitative Stock Selection - The quantitative stock selection strategy relies on mathematical models and statistical analysis to avoid subjective emotional interference, allowing for the processing of data from thousands of stocks [3] - As of June 30, 2025, the average excess return of 144 quantitative stock selection products was ***%, with the top three products being "Zeyuan Shen Sheng No. 7 A Class" from Shenzhen Zeyuan, "Jiuming Qianliang No. 1" from Jiuming Investment, and "Liangying Risheng Exclusive No. 1 A Class" from Liangying Investment [3][5] Group 3: CSI 500 Index Enhancement - The CSI 500 index enhancement products aim to seek additional returns beyond the index through quantitative methods [6] - As of June 30, 2025, the average excess return of 139 CSI 500 index enhancement products was ***%, with the top three being "Xinhong CSI 500 Index Enhancement No. 2 A Class" from Xinhong Tianhe, "Xiangmu Yongfu" from Xiangmu Asset, and "Abama Ruixue Fengnian Quantitative Selection" from Abama Investment [6][8] Group 4: CSI 1000 Index Enhancement - The CSI 1000 index enhancement products focus on actively managing investments to exceed the index benchmark [9] - As of June 30, 2025, the average excess return of 86 CSI 1000 index enhancement products was ***9%, with the top three being "Xiangmu Wangjiang No. 2" from Xiangmu Asset, "Anzi Geek CSI 1000 Enhancement No. 1 A Class" from Anzi Fund, and "Zizhu No. 2" from Tiange Investment [9][10] Group 5: CSI 300 Index Enhancement - The CSI 300 index enhancement products aim to achieve excess returns through quantitative stock selection and derivative tools [12] - As of June 30, 2025, the average excess return of 24 CSI 300 index enhancement products was ***%, with the top three being "Jiu Zhang Huan Fang CSI 300 Quantitative Multi-Strategy No. 1" from Ningbo Huan Fang, "Mingcong Stable Growth No. 2" from Mingcong Investment, and "Tote CSI 300 Index Enhancement No. 2" from Tote (Sanya) Private [12][16] Group 6: Other Index Enhancements - Other index enhancement products cater to high-net-worth individuals, including various indices such as the National Securities 2000, Sci-Tech Innovation Board Index, and others [17] - As of June 30, 2025, the average excess return of 52 other index enhancement products was ***%, with the top three being "Liangchuang Quantitative Beizheng Stock Selection No. 1 A Class" from Liangchuang Investment, "Shengguanda Stock Quantitative No. 2 C Class" from Shengguanda, and "Longqi Technology Innovation Selection No. 1 C Class" from Longqi Technology [17][20]